Clinical Trial Update: BCG Vaccination Effect on Latent Reservoir Size in Treated HIV-1 Infection: [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating whether BCG vaccination affects latent HIV-1 reservoir size in treated HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BCG vaccination (Bacillus Calmette-Guérin vaccine)

Snippet

Sponsor: University of Zurich | Conditions: HIV-1-infection | Phase 2 | Status: UNKNOWN